Dr. Reddy’s Laboratories announces voluntary recall of Sapropterin Dihydrochloride due to potency concerns

Pallavi Madhiraju- April 23, 2024 0

Dr. Reddy's Laboratories Ltd., a prominent pharmaceutical company listed on multiple stock exchanges including BSE: 500124 and NYSE: RDY, has initiated a voluntary recall of ... Read More